Mahmoud H. el Kouni - Concepedia

Author

Mahmoud H. el Kouni

University of Alabama at Birmingham ORCID

Also Known As

M H El Kouni, M H el Kouni, M Kouni, M. H. EL KOUNI, M. H. El Kouni, M. H. el Kouni, M.H. el Kouni, Mahmoud H el Kouni, Mahmoud H. El Kouni, Mahmoud H. Kouni

100

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

University of Alabama at Birmingham Brown University University of Georgia University of Rhode Island Veterans Health Administration

About

Mahmoud H. el Kouni is an author at University of Alabama at Birmingham specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	41	1.6K
2	Biochemistry	20	31	1.4K
3	Natural Sciences	18	23	793
4	Health Sciences	2	2	67
5	Allergy	1	1	45

Mahmoud H. el Kouni

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Enzymes of uracil catabolism in normal and neoplastic human tissues. Fardos N.M. Naguib, Mahmoud H. el Kouni, Sungman Cha PubMed Dihydrouracil DehydrogenaseUrologyBiosynthesisAldo-keto ReductaseBiochemistry	1985	278
Kinetic studies of thymidine phosphorylase from mouse liver Max H. Iltzsch, Mahmoud H. el Kouni, Sungman Cha Biochemistry	1985	135
Structure-activity relationship of ligands of the pyrimidine nucleoside phosphorylases John G. Niedzwicki, Mahmoud H. el Kouni, Shih Hsi Chu, Biochemical Pharmacology BiochemistryStructural BiologyStructure-activity RelationshipStructure-function Enzyme KineticsProtein Phosphorylation	1983	106
5-Benzylacyclouridine and 5-benzyloxybenzylacyclouridine, potent inhibitors of uridine phosphorylase John G. Niedzwicki, Shih Hsi Chu, Mahmoud H. el Kouni, Biochemical Pharmacology Medicinal ChemistryBiochemistryMedicineNatural SciencesMechanism Of Action	1982	90
The Adenosine Transporter of Toxoplasma gondii Chi-Wu Chiang, Nicola Carter, William J. Sullivan, Journal of Biological Chemistry	1999	81
Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases: implications for chemotherapy with 5-fluoropyrimidines. Mahmoud H. el Kouni, Mustapha M. el Kouni, Fardos N.M. Naguib PubMed Aldo-keto ReductaseMolecular BiologyChemical BiologyBroader SpecificityEnzymatic Modification	1993	79
Pyrimidine acyclonucleosides, inhibitors of uridine phosphorylase John G. Niedzwicki, Mahmoud H. el Kouni, Shih Hsi Chu, Biochemical Pharmacology Bioorganic ChemistryBiochemistryNatural SciencesPyrimidine AcyclonucleosidesChemical Biology	1981	72
Potentiation of 5-fluoro-2'-deoxyuridine antineoplastic activity by the uridine phosphorylase inhibitors benzylacyclouridine and benzyloxybenzylacyclouridine. Ming Chu, Fardos N.M. Naguib, Max H. Iltzsch, PubMed 5-Fluoro-2'-deoxyuridine Antineoplastic ActivityPharmaceutical SciencePathologyPharmacotherapyMetronomic Chemotherapy	1984	70
5-Benzylbarbituric acid derivatives, potent and specific inhibitors of uridine phosphorylase Fardos N.M. Naguib, Diane L. Levesque, Eng-Chi Wang, Biochemical Pharmacology Molecular PharmacologyMedicinal Chemistry5-Benzylbarbituric Acid DerivativesBioorganic ChemistryBiochemistry	1993	69
5-(Phenylthio)acyclouridine: a powerful enhancer of oral uridine bioavailability: relevance to chemotherapy with 5-fluorouracil and other uridine rescue regimens Omar N. Al Safarjalani, Xiao‐Jian Zhou, Reem H. Rais, Cancer Chemotherapy and Pharmacology Medicinal ChemistryUrologyPharmaceutical ScienceMedicineOral Uridine Bioavailability	2005	68

Page 1